Oftasceine

Oftasceine Overview

Oftasceine commonly known as Fluorexon or Calcein is a complex high-molecular-weight polyaminocarboxylate derivative of fluorescein. Chemically, it belongs to the class of organic compounds known as pentacarboxylic acids and derivatives within the carboxylic acids and derivatives sub-class. Structurally, it consists of a central fluorophore xanthene core conjugated to a phthalide ring and two iminodiacetic acid methyl groups, possessing a high molecular weight of 622.53 g/mol (and 710.48 g/mol as its tetrasodium salt). It presents as an orange-red powder that dissolves readily in aqueous media to produce a bright yellow-green fluorescent solution under cobalt blue or ultraviolet light.

What Is Oftasceine and How Does It Work?

Oftasceine acts primarily through molecular size exclusion from soft hydrogel polymer matrices combined with blue-light fluorescence excitation, driving real-time visualization of sub-lens tear dynamics, lens edge clearance, and corneal epithelial defects without matrix lens absorption.

Is Oftasceine FDA Approved?

Oftasceine (commonly known as fluorexon or calcein) is not approved by the U.S. Food and Drug Administration (FDA) as a human pharmaceutical drug under a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). While it is listed in the RxNorm database, recognized in international pharmacopeias, and widely utilized in optometric practice as a high-molecular-weight diagnostic fluorophore for soft contact lens fitting (historically distributed in unapproved ophthalmic strip and solution formulations such as SoftGlo and Fluoresoft), it has not received formal NDA or ANDA authorization for clinical drug distribution in the United States.

What Was/Is Oftasceine Used For?

• Evaluation of soft hydrogel and silicone-hydrogel contact lens fit, movement, centration, and sub-lens tear exchange.
• Assessment of hybrid and large-diameter scleral contact lens alignment over the cornea and limbus.
• Detection of corneal epithelial erosions, abrasions, or tight-lens hypoxic keratitis in soft contact lens wearers.
• Measurement of non-invasive tear film breakup time (TBUT) and tear meniscus height without requiring contact lens removal.

Before Taking Oftasceine: Contraindications & Precautions

Do not administer Oftasceine to patients with a known severe hypersensitivity to oftasceine, fluorexon, xanthene dyes, or paper strip components. Exercise caution when applying diagnostic strips to eyes with active, severe corneal perforations or deep penetrating ocular trauma to avoid direct intraocular anterior chamber dye contamination. Although Oftasceine exhibits significantly lower soft-lens binding than fluorescein sodium, soft contact lenses with extremely high water content (> 70%) or extended-wear hydrogels should still be rinsed with sterile saline post-examination if minor residual dye retention occurs.

Who Should Not Take Oftasceine?

• Individuals with known severe hypersensitivity or allergy to Oftasceine, Fluorexon, or xanthene dyes.
• Direct application onto eyes with active intraocular penetrating trauma.

Oftasceine, Pregnancy & Safety

Topical diagnostic application of a single paper strip delivers a tiny microgram-level dose of dye (< 0.5 mg) to the ocular surface, yielding negligible systemic absorption. Controlled clinical trials evaluating Oftasceine in pregnant women have not been formally conducted. Oftasceine is a diagnostic agent; single topical application during pregnancy carries no documented risk of embryofetal toxicity. It is safe for diagnostic use during pregnancy and lactation.

Tell Your Doctor Before Taking Oftasceine

Inform your eye care specialist if you wear high-water-content soft contact lenses, have a history of severe eye allergies, or have recently undergone corneal refractive surgery.

Oftasceine Dosage & Administration

Formulated as sterile, individually packaged paper strips (0.5 mg Oftasceine per strip).

Oftasceine dosing is limited to single diagnostic applications during eye examinations.

Standard Oftasceine Dosing

• Diagnostic Soft Contact Lens Fitting Dosing (Adults & Children): Moisten the dye-impregnated tip of 1 sterile strip with 1 to 2 drops of sterile unpreserved saline; touch the moistened tip gently against the lower palpebral conjunctiva while the soft contact lens is in place.
• Examination Timing: Instruct the patient to blink several times to distribute the dye into the sub-lens tear space; evaluate the lens fit immediately using slit-lamp biomicroscopy under cobalt blue light.

How Was/Is Oftasceine Administered

• Moisten strip tip with unpreserved sterile saline solution only (do not use acidic or highly hypertonic rewetting drops that alter fluorescence).
• Gently touch the flat, moistened tip of the strip to the lower conjunctival sac; do not rub or drag the strip across the corneal apex or contact lens surface.

Oftasceine Clinical Efficacy & Research

In clinical optometry, contact lens research, and diagnostic ophthalmology, Oftasceine (Fluorexon) is recognized as the gold-standard fluorophore for soft contact lens fitting. Comparative clinical diagnostic trials evaluating soft contact lens wearers establish that Oftasceine produces vibrant yellow-green fluorescence under cobalt blue light without penetrating hydrogel lens matrices. In contrast, standard fluorescein sodium rapidly penetrates soft lenses within 30 to 60 seconds, turning the entire lens yellow and masking sub-lens tear dynamics. Clinical studies confirm that Oftasceine allows accurate visualization of apical clearance, edge lift, and post-lens tear movement across various hydrogel and silicone-hydrogel lens designs, enabling precise lens customization and early detection of tight-lens syndrome.

Oftasceine Side Effects & Safety Profile

Oftasceine exhibits an outstanding ocular safety profile when applied as a single diagnostic strip. Safety hazards stem primarily from transient visual discoloration or rare localized allergic reactions.

Adverse effects are localized exclusively to the ocular surface.

Common Oftasceine Side Effects

• Ophthalmic Application: Temporary yellow-green discoloration of the tear film, temporary light-yellow tinting of conjunctival tissue, and mild, transient stinging upon application.

Serious Oftasceine Adverse Events

• Hypersensitivity Reactions: Rare localized allergic blepharoconjunctivitis or eyelid edema in dye-sensitized individuals.
• Minor Soft Lens Tinting (High-Water Lenses): Faint, temporary yellow tinting on soft lenses with high water content (> 70%) if left in un-flushed concentrated dye for extended periods (disappears after saline rinsing).

Managing Oftasceine Side Effects

If mild ocular stinging occurs, flush the eye gently with sterile unpreserved saline. Advise patients that temporary tear discoloration washes away naturally within a few hours. If soft lenses retain a faint yellow tint, rinse them thoroughly in a contact lens disinfecting solution.

Oftasceine Drug Interactions & What to Avoid

Oftasceine displays no systemic drug-drug interactions due to negligible systemic absorption.

Physical interactions occur primarily with topical ophthalmic preservatives and other diagnostic dyes.

Oftasceine Drug-Drug Interactions

• Benzalkonium Chloride (BAK) & Preservatives: High concentrations of quaternary ammonium preservatives can cause mild quenching of Oftasceine fluorescence; use unpreserved sterile saline to moisten diagnostic strips.
• Concurrent Diagnostic Dyes (Fluorescein Sodium): Mixing fluorescein sodium with Oftasceine alters emission spectra; use dyes sequentially with saline flushes if multiple evaluations are necessary.

Oftasceine, Food & Alcohol

Systemic food and alcohol interactions do not occur with topical ophthalmic diagnostic application.

Oftasceine: Missed Dose, Overdose & Storage

Proper handling of Oftasceine involves single diagnostic strip application in clinical settings. Overdose is non-existent with paper strip formulations.

Adherence to proper storage parameters maintains strip sterility and dye stability.

Missed Dose of Oftasceine

Not applicable. Oftasceine is administered as a single diagnostic strip by an eye care professional during a clinical examination.

Oftasceine Overdose & Emergency

Topical ocular overdose is impossible with paper strips. Accidental excess dye is flushed naturally by lacrimation or sterile saline irrigation. Systemic toxicity does not occur.

How to Store Oftasceine

Store sterile SoftGlo diagnostic strips at controlled room temperature between 15°C and 25°C (59°F to 77°F). Protect strictly from moisture, excessive humidity, and direct sunlight. Keep strips sealed in their individual sterile pouches until the moment of use. Keep out of reach of children.

Oftasceine Patient Management & Monitoring

Clinical oversight for patients receiving Oftasceine focuses on evaluating soft contact lens movement, assessing sub-lens tear exchange under slit-lamp biomicroscopy, and monitoring patient comfort.

Regular clinical tracking ensures successful contact lens fitting without corneal hypoxic compromise.

Tests Before Starting Oftasceine

Baseline slit-lamp examination; verification of contact lens type (soft hydrogel, silicone-hydrogel, or hybrid); screening for known dye allergies.

Monitoring During Oftasceine Treatment

Biomicroscopic assessment of fluorescent tear patterns under cobalt blue light; evaluation of lens centration, lag, and push-up recovery; grading corneal epithelial integrity post-lens removal.

Oftasceine Do’s and Don’ts

• Do allow your eye doctor to use Oftasceine strips while wearing your soft contact lenses to check their fit.
• Do blink normally after the dye is applied to distribute it evenly under the lens.
• Do rinse your soft contact lenses with fresh saline if a faint yellow tint remains after the examination.
• Do not attempt to use regular Fluorescein Sodium strips on soft contact lenses (it will permanently stain them).
• Do not rub your eyes immediately after diagnostic strip application.

Frequently Asked Questions

References

• DrugBank Database – Oftasceine Clinical Profile (DB11184)
• Classyfire Database – Pentacarboxylic Acids and Derivatives / Carboxylic Acids Taxonomy Profile
• Contact Lens and Anterior Eye Journal – Diagnostic Fluorophores in Soft and Hybrid Contact Lens Fitting

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.